{"id":"W4231344750","doi":"10.1097/00054725-200812003-00108","title":"Estimation of induction and maintenance costs of Infliximab, Adalimumab and Certolizumab Pegol in managing Crohnʼs Disease","year":2008,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Certolizumab pegol; Adalimumab; Medicine; Infliximab; Maintenance therapy; Crohn's disease; Internal medicine; Regimen; Population; Cohort; Surgery; Disease; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001915904,0.0009860735,0.0008878409,0.001809641,0.0003274919,0.001711931,0.001289022,0.001371452,0.002910568],"category_scores_gemma":[0.008436874,0.001040376,0.001662888,0.002120613,0.0003951413,0.001919549,0.0007060082,0.001100479,0.0003389851],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004989229,"about_ca_system_score_gemma":0.003288907,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04080039,"about_ca_topic_score_gemma":0.01935687,"domain_scores_codex":[0.9994401,0.0002526133,0.00004721146,0.00006576527,0.00009717215,0.0000970999],"domain_scores_gemma":[0.9959849,0.00289492,0.0004336019,0.00009583463,0.0003752809,0.0002154645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.0002689403,0.00006280041,0.01038018,0.0001267041,0.0001346255,0.0002827872,0.00003698002,0.9789172,0.0001962319,0.002736342,0.0006284448,0.006228648],"study_design_scores_gemma":[0.0000811184,0.0001440793,0.009451379,0.00008259826,0.0001777887,0.0002508866,0.0001540084,0.985868,0.0003121292,0.002287265,0.001157404,0.00003324445],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9162358,0.004000022,0.05693691,0.00117365,0.00009982979,0.000473485,0.007011787,0.0001408953,0.01392761],"genre_scores_gemma":[0.9827741,0.000938517,0.01182744,0.00006368107,0.00001967483,0.000229111,0.001648177,0.00002722641,0.002472121],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04080039,"threshold_uncertainty_score":0.0811258,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007342314011025667,"score_gpt":0.2255077788302458,"score_spread":0.2181654648192202,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}